GLPGF OTC
Lakefront Biotherapeutics
1W: +0.0%
1M: +21.8%
3M: +13.8%
YTD: +2.1%
1Y: -4.5%
3Y: -19.1%
5Y: -72.8%
$31.95
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$3.4B
-17.7% ▼
5Y CAGR: -9.8%
Total Liabilities
$171M
-86.2% ▼
5Y CAGR: -43.8%
Shareholders Equity
$3.2B
+11.7% ▲
5Y CAGR: +3.9%
Cash & Investments
$3.0B
-3.9% ▼
5Y CAGR: -10.3%
Total Debt
$12M
+3.2% ▲
5Y CAGR: -16.3%
Net Debt
-$76M
-44.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.2B | $508M | $167M | $64M | $88M |
| Short-Term Investments | $2.5B | $3.6B | $3.5B | $3.1B | $2.9B |
| Cash & ST Investments | $4.7B | $4.1B | $3.7B | $3.1B | $3.0B |
| Net Receivables | $129M | $77M | $66M | $88M | $52M |
| Inventory | $21M | $53M | $74M | $51M | $22M |
| Other Current Assets | $9M | $12M | $37M | $82M | $7M |
| Total Current Assets | $4.9B | $4.2B | $3.9B | $3.3B | $3.1B |
| Property, Plant & Equip. | $138M | $154M | $126M | $123M | $81M |
| Goodwill & Intangibles | $60M | $216M | $197M | $235M | $848K |
| Long-Term Investments | $127M | $125M | $14M | $253M | $221M |
| Other Non-Current Assets | $2M | $1M | $157M | $184M | $24M |
| Total Non-Current Assets | $331M | $498M | $496M | $796M | $327M |
| Total Assets | $5.2B | $4.7B | $4.4B | $4.1B | $3.4B |
| — Liabilities — | |||||
| Accounts Payable | $134M | $133M | $135M | $98M | $105M |
| Short-Term Debt | $0 | $0 | $0 | -$1M | $2M |
| Deferred Revenue | $420M | $366M | $0 | $232M | $32K |
| Other Current Liabilities | $204K | $9M | $288M | $1M | $45M |
| Total Current Liabilities | $566M | $523M | $428M | $335M | $153M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $5M |
| Other Non-Current Liab. | $7M | $27M | $34M | $36M | $7M |
| Total Non-Current Liabilities | $2.0B | $1.7B | $1.1B | $904M | $18M |
| Total Liabilities | $2.5B | $2.2B | $1.6B | $1.2B | $171M |
| — Equity — | |||||
| Common Stock | $292M | $294M | $294M | $294M | $294M |
| Retained Earnings | -$367M | -$497M | -$228M | -$134M | $210M |
| Accumulated OCI | -$12M | -$6M | -$7M | $314K | $3M |
| Total Stockholders Equity | $2.6B | $2.5B | $2.8B | $2.9B | $3.2B |
| Total Liabilities & Equity | $5.2B | $4.7B | $4.4B | $4.1B | $3.4B |
| — Key Metrics — | |||||
| Total Debt | $27M | $22M | $10M | $12M | $12M |
| Net Debt | -$2.2B | -$486M | -$157M | -$53M | -$76M |
| Total Investments | $2.6B | $3.7B | $3.5B | $3.3B | $3.1B |